ATR and cancer: A recent study testing the effects of inhibition of ATR kinase, a master regulator of the DDR, found that ATR was an attractive target for cancer therapy, as many cancers have defects in certain components of the DDR that render them highly dependent on the remaining DDR pathways for survival (41).